Details for New Drug Application (NDA): 017768
✉ Email this page to a colleague
▶ Start for $100
Remove trial restrictions
The generic ingredient in HIBICLENS is chlorhexidine gluconate. There are fifty-eight drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the chlorhexidine gluconate profile page.
Summary for 017768
Tradename: | HIBICLENS |
Applicant: | Molnlycke Hlth |
Ingredient: | chlorhexidine gluconate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 017768
Physiological Effect | Decreased Cell Wall Integrity |
Medical Subject Heading (MeSH) Categories for 017768
Suppliers and Packaging for NDA: 017768
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
HIBICLENS | chlorhexidine gluconate | SOLUTION;TOPICAL | 017768 | NDA | Georgia-Pacific Consumer Products LP | 54622-575 | 54622-575-73 | 1200 mL in 1 BOTTLE, DISPENSING (54622-575-73) |
HIBICLENS | chlorhexidine gluconate | SOLUTION;TOPICAL | 017768 | NDA | Asclemed USA, Inc. | 76420-535 | 76420-535-08 | 236 mL in 1 BOTTLE (76420-535-08) |
Profile for product number 001
Active Rx/OTC/Discontinued: | OTC | Dosage: | SOLUTION;TOPICAL | Strength | 4% | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes |
Expired US Patents for NDA 017768
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Molnlycke Hlth | HIBICLENS | chlorhexidine gluconate | SOLUTION;TOPICAL | 017768-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Molnlycke Hlth | HIBICLENS | chlorhexidine gluconate | SOLUTION;TOPICAL | 017768-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription